These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29388750)

  • 21. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of Coagulation Factors Deficiency among Young Adults in Saudi Arabia: A National Survey.
    AlSaleh KA; Al-Numair N; AlSuliman A; Zolaly M; Albanyan AM; AlOtaishan N; Abudouleh E; Bayoumy N; Tarawah A; AlZahrani F; AlAllaf F; AlMomen AK; Sajid R; Owaidah TM
    TH Open; 2020 Oct; 4(4):e457-e462. PubMed ID: 33376945
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemostatic patterns and bleeding scores of a genetically characterised Italian family with combined haemophilia A and type 1 von Willebrand disease.
    Daidone V; Pontara E; Boscaro F; Cattini MG; Milan M; Casonato A
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):230-233. PubMed ID: 27380589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system.
    Ågren A; Holmström M; Schmidt DE; Hosokawa K; Blombäck M; Hjemdahl P
    Thromb Haemost; 2017 Jan; 117(1):75-85. PubMed ID: 27761577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.
    Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y
    Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions.
    Favaloro EJ
    Semin Thromb Hemost; 2014 Jul; 40(5):551-70. PubMed ID: 24978322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe postpartum haemorrhage as first presenting symptom of an inherited bleeding disorder.
    Veen CSB; van der Reijken IS; Jansen AJG; Schipaanboord CWA; Visser W; de Maat MPM; Leebeek FWG; Duvekot JJ; Kruip MJHA
    Haemophilia; 2019 Nov; 25(6):1051-1058. PubMed ID: 31583797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
    Othman M
    Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
    Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.
    van Meegeren ME; Mancini TL; Schoormans SC; van Haren BJ; van Duren C; Diekstra A; Laros-van Gorkom BA; Brons PP; Simons A; Hoefsloot L; van Heerde WL
    Haemophilia; 2015 Sep; 21(5):e375-83. PubMed ID: 26207643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children.
    Akin M; Karapinar DY; Balkan C; Ay Y; Kavakli K
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):441-8. PubMed ID: 20460340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of inherited bleeding disorders in women with menorrhagia.
    Kadir RA; Economides DL; Sabin CA; Owens D; Lee CA
    Lancet; 1998 Feb; 351(9101):485-9. PubMed ID: 9482440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.